Skip to content

Shweta Karvirpallavadi Taila and Kustumburvadi Lepa application after Vamana and Virechana Karma in Mandal Kushtha (Plaque Psoriasis).

A Comparative Clinical Study of Shweta Karvirpallavadi Taila and Kustumburvadi Lepa application after Shodhana in the management of Mandal Kushtha with special reference to Plaque Psoriasis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033504
Enrollment
30
Registered
2021-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

Intervention1: Post Shodhan Shweta Karvirpallavadi Taila: Shodhana Karma (Vamana & Virechana) followed by Shweta Karvirpallavadi Taila application for 15 days will be done in 15 patients. Control Inte

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 18 to 60 years of age. 2. Patients with the classical features of Mandal Kushtha (Plaque Psoriasis). 3. Patients not taking any other medicine for Mandal Kushtha (Plaque Psoriasis). 4. Patients fit for Vamana and Virechana Karma. 5. Patients willing to sign consent form for trial.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating mothers. 2. Patients suffering from systemic disorders as Cardiac Problem, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, HIV, HBsAg, Leprosy. 3. Patients suffering from Psoriatic Arthritis. 4. Patients unfit for Vamana and Virechana Karma .

Design outcomes

Primary

MeasureTime frame
PASI ScoreTimepoint: 0 and 65 days

Secondary

MeasureTime frame
Kandu (Itching) Mandal Roopa (Oval/Round shape) Shoka Chinta (Anxiety) DERMATOLOGY LIFE QUALITY INDEX (DLQI)Timepoint: 0 and 65 days

Countries

India

Contacts

Public ContactDr Gopesh Mangal

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026